Sudeep Pharma Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

SUDEEPPHRM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.5%1-day move

₹633.55

prior close

₹636.55

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.4+0.4+0.4+0.4+2.5+2.6+2.1+2.4+5.0+9.9+19.6+29.3+32.6—

Up moveDown movePending

AI summary

Sudeep Pharma Limited has informed NSE and BSE about a scheduled earnings call on Friday, 22nd May 2026 at 11:00 AM IST. The call is to discuss the company's operational and financial performance for Q4 and the full year ended 31st March 2026 (FY26). The company's leadership team — including Managing Director Mr. Sujit Bhayani, Director Mr. Shanil Bhayani, and CFO Mr. Ketan Vyas — will participate. The company has filed this under Regulation 30 of the SEBI Listing Regulations, 2015. Pre-registration is required and access numbers for international participants are provided. A copy of the invite is hosted on the company's investor relations website.

Likely market impact

This is a routine disclosure indicating transparent investor communication. It gives shareholders and analysts an opportunity to directly interact with management and gain insights into Q4 and FY26 performance. The participation of the MD, Director, and CFO signals management engagement and openness.